Product Liability and Mass Torts

Overview

The product liability and mass torts working group assists manufacturers with risk assessment, labeling, crisis management, tort liability issues, exposure issues and product warranties. Our multidisciplinary team helps manufacturers avoid, mitigate and defend against product liability, class actions and mass torts arising from injuries occurring in the United States and abroad relating to COVID-19. We can help you develop and execute a comprehensive approach to guide you through this complex and fast‐moving situation, counsel you on applicable regulations providing immunity to certain manufacturers and distributors of COVID-19 related products, including the PREP Act and other state and federal regulations, help walk you through amending contracts to mitigate future tort liability, and partner with you to defend against any claims or litigation that may arise from the global pandemic.

Product Liability and Mass Torts

Overview

Contacts

Partner

Partner

Insights

Insights

Indiana Passes COVID-19 Civil Tort Immunity Bill

Can Businesses Limit Exposure to Product Liability Claims Related to COVID-19?

HHS Amends PREP Act Declaration to Facilitate Vaccine Rollout

HHS Issues New PREP Act Immunity to Marburgvirus Countermeasures

Tips on Virtual Expert Witness Deposition Testimony – Part Two

Tips on Virtual Expert Witness Deposition Testimony – Part One

FDA Issues Guidance on Conduct of Clinical Trials of Medical Products During COVID 19 Pandemic

COVID-19 Weekly Newsletter: Case Count, Death Toll Both Rising as Public Health Officials Work to Instill Confidence in a Vaccine

Frequently Asked Questions on COVID-19 Personal Injury Litigation

PREP Act Does Not Require Federal Forum for State Law Negligence Claims Related to COVID-19

COVID-19 and Design Defect Jurors’ Risk Evaluations

The Ship Has Sailed on Plaintiffs’ Efforts to Recover for Mere Fear of Contracting COVID-19

What Product Liability Claims Can We Expect to See as a Result of COVID-19?

FDA’s Revocation of the Hydroxychloroquine and Chloroquine EUA May Test the Limits of PREP Act Immunity

Beware the COVID-19 Cure: The FTC Issues Warnings to Products Making COVID-19 Treatment Claims

“Deposition Distancing”: Practical Considerations for Defending Remote Depositions

“Deposition Distancing”: Practical Considerations for Taking Remote Depositions

Deposition Distancing? As Courts Urge Litigants to Continue Discovery with Remote Depositions, Litigants Must Consider Whether, and When, to Fight Them

FDA Gives Guidance on Reporting Medical Device Shortages

Do State Executive and Emergency Orders Offer Any Product Liability Protection Amidst the COVID-19 Outbreak?

FDA Releases Guidance Requiring Notification of Certain Medical Device Shortages Related to COVID-19 Testing and Treatment

Effectively Navigating PREP Act Case Law – The Products Liability Perspective

PREP Act Case Law and Its Application to Today’s COVID-19 Crisis

Whether Negligence, IP or Contract Claims – All May Be Covered Under PREP Act Immunity

Preparing for the COVID-19 Immunity Preemption Defense

Do State Good Samaritan Laws Offer Any Product Liability Protection?

FAQs: Are Component Part Manufacturers Entitled to Immunity Under the PREP Act, the CARES Act or the DPA?

HHS Issues Advisory Opinion on PREP Act Declaration Immunity

CARES Act Expands Liability Protections Under the PREP Act

FDA Eases Menu Labeling Requirements for Chain Restaurants and Retail Food Establishments During the COVID-19 Pandemic

HHS PREP Act Declaration Offers Broad-Based Tort Immunity to Those Involved in COVID-19 Fight

COVID-19 Resource Center Home